
Symbyax was approved by the FDA to treat the depressive episodes of bipolar I disorder in 2003. In 2009, it was granted approval for the treatment of treatment-resistant depression. Symbyax, or other antidepressant/antipsychotic combinations, are sometimes prescribed off-label for anxiety disorders, eating disorders, OCD, and PTSD. Adapted from the Wikipedia article Olanzapine/fluoxetine, under the G. [...]










